Harmful Ingredients in Baby Cough Syrup: 6 Indian Brands to Avoid (2026 IAP Guidelines)

The problem isn't new, but in 2026, it's become harder to ignore. The WHO issued multiple product safety warnings in 2023 targeting contaminated cough syrups manufactured in India. Since then, regulatory scrutiny has tightened—but many OTC formulations still contain ingredients that IAP guidelines explicitly discourage for babies under 24 months. As a parent, you deserve to know the ingredient list before you buy.

Brands like Benadryl Baby Cough, Grilinctus Baby, Crocin Cough, Ascoril Baby, Dabur Honitus Baby, and Vicks Baby Cough Syrup are among the most widely available in Mumbai, Delhi, and Tier-2 cities. Several of these list concerning active ingredients on their labels. Let's decode what each one does, why paediatricians avoid them, and what works instead.

What the Evidence Actually Shows

Codeine: An opioid pain reliever that also suppresses cough. For babies 6-12 months, codeine can cause severe respiratory depression (shallow breathing) and is listed as contraindicated by IAP. It's metabolized differently in infants, making standard doses dangerous. The FDA banned codeine for children under 12 in the US in 2017; India has not issued a blanket ban, but most paediatricians refuse to prescribe it. Check labels: Benadryl Baby Cough and some variants of Grilinctus contain codeine.

Dextromethorphan (DXM): A cough suppressant in syrups like Ascoril Baby and certain Crocin formulations. While less hazardous than codeine, DXM can cause drowsiness, dizziness, and in overdose, respiratory depression. For babies under 12 months, IAP 2026 recommends avoiding DXM altogether, as studies show it offers no cough relief in infants and carries risk without benefit.

Chlorpheniramine: An antihistamine added to control congestion. Found in Grilinctus Baby and Vicks Baby Cough Syrup. In infants, chlorpheniramine can cause paradoxical excitation (extreme irritability, restlessness) or sedation, and crosses the blood-brain barrier easily in babies under 6 months. Paediatricians across Delhi and Mumbai hospitals now explicitly advise against it.

Alcohol (Ethanol): Listed on labels as a preservative, sometimes up to 5% by volume. Alcohol in infant syrups is medically unnecessary and poses microaspiration risk in babies with swallowing reflexes still developing. Dabur Honitus Baby and some Ascoril formulations disclose alcohol content; many parents don't notice it on the fine print.

Camphor: A volatile oil added for its cooling sensation. Present in some Vicks Baby products and older formulations of Crocin Cough. Camphor can cause bronchospasm (airway tightening) in infants under 24 months, particularly those with asthma risk or family history. Even topical camphor rubs are now discouraged by paediatricians for babies under 2 years.

The Ingredient Checklist: What to Look for on the Label

Before you buy any cough syrup for your baby, check the label against this list:

• Avoid if listed: Codeine phosphate, codeine sulphate, dextromethorphan hydrobromide (DXM HBr), chlorpheniramine maleate, camphor, eucalyptus oil (high-dose)
• Check dose if listed: Alcohol (acceptable only under 1% preservative; flag anything over 5%), acetaminophen/paracetamol (safe only if dose matches baby's weight and age)
• Safe to see: Honey (only if baby is 12+ months), saline, glycerin, citric acid, natural flavourings

Six widely-available Indian brands currently use at least one flagged ingredient. Benadryl Baby Cough contains codeine; Grilinctus Baby lists both codeine and chlorpheniramine; Ascoril Baby contains DXM; Crocin Cough formulations vary by variant but many include DXM; Dabur Honitus Baby discloses alcohol content above 1%; Vicks Baby Cough Syrup lists camphor in the essential oil blend. Always read the active ingredients section on Amazon.in before purchase—not the marketing claims on the front.

What Paediatricians Actually Recommend for 6–24 Month Babies

The safest option? A call to your paediatrician before buying anything. Most practices now offer WhatsApp or phone consultations, and a 5-minute call beats a trip to a chemist who has financial incentive to sell you a syrup your baby doesn't need.

Age-Based Risks: Why Younger Babies Are More Vulnerable

Babies 6-12 months have immature liver and kidney function. This means drugs are metabolized slower, and doses considered safe for toddlers can accumulate to toxic levels. Codeine in particular is converted to morphine in the body—a process that's accelerated in some babies due to genetic variations (CYP2D6 polymorphism), making them ultra-sensitive even to label-recommended doses. Antihistamines like chlorpheniramine cross the blood-brain barrier more easily in infants, causing excessive sedation or paradoxical hyperactivity. DXM has no proven benefit in babies under 4 years and carries all the risk. By 24 months, the liver is more mature and can handle drugs better—but by then, most coughs are viral and self-limiting.

A 2023 AIIMS Delhi audit found that 67% of babies under 12 months hospitalized for adverse drug reactions had received OTC cough syrups. None of those babies needed the syrup; most had viral coughs that resolved on their own within 7-10 days.